Cargando...

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

The identification of individuals at risk for Alzheimer's disease (AD) is essential for the timely administration of treatment approaches aimed at slowing the onset or progression of the disease. As amnestic forms of mild cognitive impairment (aMCI) may represent preclinical AD, the search for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Counts, Scott E., Mufson, Elliott J.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3035316/
https://ncbi.nlm.nih.gov/pubmed/21311725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10134-010-0004-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!